600 patients66,869 observations120 daysLIVE

Patient P-01746

Synthetic patientNBL-101 · Day 102 · 75+ · M · baseline S14Steering view · 3DOpen companion preview
Therapy response
Stable
Tolerance
Improving
GI state
Improving
Inflammatory state
Improving
Nutritional resilience
Improving
Discontinuation risk
74%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 NBL-101 startedBaseline state S14
  2. Day 31 NP-02 recommendedDietary Support Protocol NP-02
  3. Day 32 Patient acceptedStarted NP-02 in the companion
  4. Day 42 GI symptom burden −25% vs expectedDietary Support Protocol NP-02
  5. Day 48 Tolerance state changedUnstable → Improving
  6. Day 55 Trajectory diverged from predictionObserved response fell below the model's expected path.
  7. Day 68 ME-01 recommendedMonitoring Escalation ME-01
  8. Day 69 Patient acceptedStarted ME-01 in the companion
  9. Day 72 Deterioration detected before clinical escalationMonitoring Escalation ME-01

What changed?

Trajectory began diverging from predicted response on Day 55.

Primary contributors, last 14 days
  • GI instability-25
  • Inflammatory activity-22
  • Nutritional resilience+10
  • Toxicity-8

What helped?

  • Dietary Support Protocol NP-02Day 31
    Result: symptom burden −25%
  • Monitoring Escalation ME-01Day 68
    Result: deterioration detected before clinical escalation
LIFE OS recommendation
GI Support Protocol GI-04
80%
probability of meaningful tolerance improvement
  • 284 similar trajectories
  • 84% showed improvement
  • median effect visible after 8 days

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

GI burden
Companion
40.2/100
improving · -5.2 vs previous 14 d
Toxicity
Blood
31.1/100
stable · -1.2 vs previous 14 d
Sleep quality
Wearable
49.6/100
stable · +0.4 vs previous 14 d
Energy level
Daily log
4.6/10
stable · -0.1 vs previous 14 d
Stress level
Daily log
4.8/10
improving · -0.5 vs previous 14 d
Steps
Wearable
4,394
worsening · -223 vs previous 14 d
Adherence
Companion
46.9 %
stable · -1.1 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →

Heading towards restoration · 48 from the failing basin, 41 from restoration.

Would help
  • GI-04 GI Support Protocol
    73% improved among 124 similar · onset 8 d · confidence 80%
  • CR-01 Clinician Review
    100% improved among 6 similar · onset 5 d · confidence 66%
Would not help
  • Keep fat low
    GI +7.1 next day on high-intake days · n 23
  • Keep histamine low
    GI +6.4 next day on high-intake days · n 20
State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

  • Dietary fat load
    +7.1detractor · 95%
  • Histamine load
    +6.4detractor · 95%
  • Simple carbohydrates
    -2.1no signal · 40%
  • Insoluble fibre
    -1.7no signal · 30%
  • Spicy / capsaicin
    +1.6no signal · 28%
  • Alcohol
    -0.8no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure
  • Butyrate / short-chain fatty acid production 35
    • MicrobiomeButyrate capacity 22/100
  • Drug metabolism and exposure 35
    • DNADPYD *2A → slower clearance
  • Mucosal barrier integrity 30
    • DNAFUT2 non-secretor lowers mucosal fucosylation
DNA
Fictional pharmacogenomic panel
  • FUT2 rs601338 AA (non-secretor)
    Reduced mucosal fucosylation
  • DPYD *2A heterozygous
    Slower drug clearance
  • CYP2D6 Rapid metabolizer
    Expected exposure
  • MTHFR C677T
    Reduced folate turnover
Microbiome
Shannon diversity 3.1 · butyrate capacity 22/100
  • Akkermansia muciniphilaNormal
  • Faecalibacterium prausnitziiNormal
  • Bacteroides fragilisNormal
  • Bifidobacterium longumLow
  • EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
HRV
53 ms
Sleep
6.4 h
Steps
3,767
Resting HR
68 bpm
Daily log: GI score 40, nutritional resilience 51, adherence 47.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview
What to eat
  • Prepare a plain, low-fat pasta or rice meal and note how it feels afterwards
  • Choose a freshly cooked, lean protein; avoid frying, rich sauces and leftovers for now
  • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
  • Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
  • Track each bowel movement today: time, stool form, urgency, overnight waking
  • A 15-minute walk after lunch
  • Keep the sleep window steady
  • Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
  • Take the scheduled dose as agreed with your care team
  • Electrolyte solution, one sachet after any loose stool
  • Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

PatientSimilarityBaselineInterventionOutcomeResponse today
P-0145851%S14GI-04improved44
P-0155949%S06GI-04improved42
P-0156849%S14GI-04improved40
P-0171349%S04GI-04improved46
P-0135648%S14GI-04improved42
P-0156648%S09GI-04improved52
P-0138946%S14SC-12improved46
P-0167846%S14GI-04improved44
P-0136545%S14SC-12improved49
P-0161745%S14SC-12improved50
P-0178145%S14NP-02improved45
P-0137644%S14GI-04improved53